Gordon Duncan

Consultant Physician / Hon Clinical Senior Lecturer / NRS Clinical Fellow

NHS England

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gordon Duncan is a Consultant Physician and Honorary Clinical Senior Lecturer at NHS Lothian in the United Kingdom. His research primarily focuses on neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease, as evidenced by his recent contributions to clinical trials and systematic reviews. His work investigates various treatment modalities and their effects on physical performance, cognitive symptoms, and muscle mass in affected populations.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Camille Carroll

Clinical Professor

Newcastle University

UNITED KINGDOM

View details

Jacob George

Professor of Cardiovascular Medicine and Therapeutics

University of Dundee

UNITED KINGDOM

View details

Julie Whitney

King's College Hospital

UNITED KINGDOM

View details

Roy Soiza

University of Aberdeen

UNITED KINGDOM

View details

Nirosen Vijiaratnam

Head of Movement disorders service

Monash Health

AUSTRALIA

View details

Harnish Patel

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gordon Duncan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease.

Effect of perindopril or leucine on physical performance in older people with sarcopenia

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.

Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.

Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review

Collaborators (6)

Camille Carroll

Jacob George

Julie Whitney

Roy Soiza

Nirosen Vijiaratnam

Harnish Patel

Make your next move.